These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 29788932)

  • 1. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.
    Chandrasekaran R; Mac Aogáin M; Chalmers JD; Elborn SJ; Chotirmall SH
    BMC Pulm Med; 2018 May; 18(1):83. PubMed ID: 29788932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungi in Bronchiectasis: A Concise Review.
    Máiz L; Nieto R; Cantón R; Gómez G de la Pedrosa E; Martinez-García MÁ
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology and characteristics of patients with bronchiectasis in Taiwan: a cohort study from 2002 to 2016.
    Huang HY; Chung FT; Lo CY; Lin HC; Huang YT; Yeh CH; Lin CW; Huang YC; Wang CH
    BMC Pulm Med; 2020 Feb; 20(1):45. PubMed ID: 32070324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients.
    Dimakou K; Triantafillidou C; Toumbis M; Tsikritsaki K; Malagari K; Bakakos P
    Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aetiology of bronchiectasis in Guangzhou, southern China.
    Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Li HM; Lin ZM; Zheng JP; Chen RC; Zhong NS
    Respirology; 2015 Jul; 20(5):739-48. PubMed ID: 25819403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung microbiome: new insights into bronchiectasis' outcome.
    Azoicai A; Lupu A; Alexoae MM; Starcea IM; Mocanu A; Lupu VV; Mitrofan EC; Nedelcu AH; Tepordei RT; Munteanu D; Mitrofan C; Salaru DL; Ioniuc I
    Front Cell Infect Microbiol; 2024; 14():1405399. PubMed ID: 38895737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of bronchiectasis.
    Nigro M; Laska IF; Traversi L; Simonetta E; Polverino E
    Eur Respir Rev; 2024 Oct; 33(174):. PubMed ID: 39384303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study.
    Mac Aogáin M; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Hassan T; Ong TH; Hui Qi Ng A; Bertrand D; Koh JY; Pang SL; Lee ZY; Gwee XW; Martinus C; Sio YY; Matta SA; Chew FT; Keir HR; Connolly JE; Abisheganaden JA; Koh MS; Nagarajan N; Chalmers JD; Chotirmall SH
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29880655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aetiology of bronchiectasis in adults: A systematic literature review.
    Gao YH; Guan WJ; Liu SX; Wang L; Cui JJ; Chen RC; Zhang GJ
    Respirology; 2016 Nov; 21(8):1376-1383. PubMed ID: 27321896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The microbiome in bronchiectasis.
    Richardson H; Dicker AJ; Barclay H; Chalmers JD
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31484665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology.
    Boyton RJ; Altmann DM
    Annu Rev Pathol; 2016 May; 11():523-54. PubMed ID: 26980162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Taylor SL; Woodman RJ; Chen AC; Burr LD; Gordon DL; McGuckin MA; Wesselingh S; Rogers GB
    Thorax; 2017 Apr; 72(4):304-310. PubMed ID: 27503233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection and the microbiome in bronchiectasis.
    Mac Aogáin M; Dicker AJ; Mertsch P; Chotirmall SH
    Eur Respir Rev; 2024 Jul; 33(173):. PubMed ID: 38960615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
    Bilton D; Henig N; Morrissey B; Gotfried M
    Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.